Search the Newsreel

AJB Investment Fund II buys $9,880 of Jewett Cameron Trading Co Ltd shares By Investing.com

AJB Investment Fund II, a significant shareholder and director of Jewett Cameron Trading Co Ltd (NASDAQ: JCTC), recently purchased an additional $9,880 worth of the company's common stock through open market transactions on August 5 and 6, 2026. These purchases, made at prices between …

Richard Young Buys 16,378 Shares of CAMP4 Therapeutics (NASDAQ:CAMP) Stock

Richard Young, a director at CAMP4 Therapeutics (NASDAQ:CAMP), recently purchased 16,378 shares at $1.65 each, increasing his total holdings by 9.63% to 186,388 shares. Despite this insider buying, the stock fell 3.6% to $4.01 after the company reported a larger-than-expected quarterly loss of $0.32 …

Camden Property Trust Revenue Breakdown – TRADEGATE:CAL

Camden Property Trust (TRADGATE:CAL) generated 1.34 billion EUR in revenue last year, primarily from its Same Store Communities segment, which contributed 1.24 billion EUR. The United States was the largest geographical contributor, accounting for 1.37 billion EUR. This data provides a breakdown of the …

Kokuyo Camlin Appoints Ms. Urvi Upadhyay and Ms. Sarika More as Company Secretary and Compliance Officer

Cameco Gains 7% Despite Q2 Earnings Miss: How to Play the Stock?

Cameco reported a Q2 earnings miss with adjusted earnings down 75% year-over-year, yet its shares rose 7% due to investor focus on long-term prospects. The company's revenues declined by 7% despite higher prices, primarily due to lower uranium sales volumes and a significant reduction …

Camden Property Trust stock underperforms Thursday when compared to competitors

Camden Property Trust (CPT) shares fell 1.05% on Thursday, closing at $110.74, underperforming the broader market. This decline occurred during a generally down day for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also posting losses. The stock's …

BlackRock pays $1.6B for Camden’s last SoCal apartments

BlackRock has acquired 11 apartment complexes from Camden Property Trust in Southern California for $1.6 billion, marking Camden's exit from the state. This transaction, involving 3,620 units across multiple counties, is one of the largest multifamily deals in the region's history. The purchase was …

FMR LLC boosts disclosure of 7.9% Camden National Corp (CAC) ownership stake

FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 1,330,676.75 shares, or 7.9%, of Camden National Corp (CAC) common stock. The filing indicates FMR LLC holds sole voting power over 1,330,065 shares and sole dispositive power over all 1,330,676.75 shares. …

Kokuyo Camlin Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Camtek Ltd. (CAMT) Stock Price, News, Quote & History

This page provides comprehensive financial information for Camtek Ltd. (CAMT), including its current stock price, historical data, key statistics, and an overview of the company's operations in the semiconductor equipment industry. It also features performance comparisons, earnings trends, analyst insights, and valuation measures.

Earnings call transcript: Campus Activewear Q1 2027 growth lifts outlook, shares slip

Campus Activewear Reports Double-Digit Revenue Growth in Q1 FY27

Camden Property Trust Sells $1.6B Multifamily Portfolio in Southern California

Camden Property Trust has sold a portfolio of 11 multifamily properties in Southern California for $1.6 billion to an entity managed by BlackRock Inc. The portfolio, comprising 3,620 units, had a 96 percent occupancy rate at the time of sale. JLL Capital Markets brokered …

Amundi Has $7.77 Million Stock Position in Camden Property Trust $CPT

Camden National (NASDAQ: CAC) doubles year-to-date 2026 earnings

Campus Activewear releases Q1FY27 earnings call audio recording

Campus Activewear standalone net profit rises 17.75% in the June 2026 quarter

Camplify Holdings (ASX:CHL) Gains as RV Marketplace Activity Faces a Margin Test

Precision Trading with Camtek Ltd. (CAMT) Risk Zones

This article provides an AI-generated analysis for Camtek Ltd. (CAMT), highlighting current market sentiment, risk zones, and various trading strategies. It outlines distinct entry and exit points, target prices, and stop losses for position trading, momentum breakout, and risk hedging, based on near-term, mid-term, …

Yuri Maricich Acquires 6,551 Shares of CAMP4 Therapeutics (NASDAQ:CAMP) Stock

Yuri Maricich, an insider at CAMP4 Therapeutics (NASDAQ:CAMP), recently acquired 6,551 shares at $1.65 each, increasing their total holdings by over 108% to 12,611 shares. This comes as the company's stock has fallen, and it reported a quarterly loss that missed analyst estimates. Despite …

CAMP4 Therapeutics (NASDAQ:CAMP) CEO Josh Mandel-Brehm Purchases 6,551 Shares

Insider Buying: CAMP4 Therapeutics (NASDAQ:CAMP) CFO Buys $10,809.15 in Stock

5AM Ventures group updates CAMP4 Therapeutics (CAMP) stake and warrant terms

5AM Ventures group has updated its stake in CAMP4 Therapeutics (CAMP) following a second closing of a financing round on August 3, 2026. The group's affiliated entities collectively beneficially own approximately 9.99% of common stock for Andrew J. Schwab and 9.98% for Dr. Kush …

Camtek (CAMT) Dips More Than Broader Market: What You Should Know

Camtek (CAMT) closed at $147.60 in the latest trading session, marking a -2.65% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.17%. Elsewhere, the Dow saw an upswing of 0.49%, while the tech-heavy Nasdaq depreciated by …

SOCAM Development Signals Interim Profit Turnaround on Construction Strength and FX Gains

Earnings call transcript: Campbell’s Q3 2026 results show slight EPS beat

Uranium Stalled at $86 Despite Tightening Supply: What Changes Above $87.40?

Uranium prices have stalled around $86 per pound despite tightening global supply and increased production from key players like Kazatomprom and Cameco. Western Australia's mining ban continues to restrict new supply, while new mine developments typically take 10-20 years, delaying significant supply increases. A …

CAMECO CORP : BARCLAYS CUTS TARGET PRICE TO $97 FROM $104

Barclays has reduced its target price for Cameco Corp (CCJ.N) shares to $97 from the previous $104. This information, released by Reuters, is presented as an author's opinion and not as investment advice.

Camden Property Trust Announces Executive Leadership Transition

Camden Property Trust announced that D. Keith Oden, Executive Vice Chairman of the Board of Trust Managers, will retire from his executive role on August 31, 2026, but will remain on the Board. Analysts currently rate CPT stock as a Hold with a $111.00 …

Cameco Stock Tops 3 High Growth Industrial Picks For Long Term Watchlists

How Camden National’s Profit Jump and Buybacks In 2026Q2 At Camden National (CAC) Has Changed Its Investment Story

3 of the Best Dividend Stocks to Buy in August 2026

Dividend stocks can be highly valuable investments to hold for the long term. In addition to dividend income, they have the potential to generate slow but modest gains over time. The problem these days is that with the stock market being as hot as …

Camden’s Keith Oden retires

Keith Oden, co-founder of Camden Property Trust, is retiring from his executive role on August 31, marking the completion of the REIT's multiyear succession plan. Oden will remain on the board of trust managers and is recognized for his significant contributions to Camden's success, …

Cosa Announces Results of Partner Funded Airborne Radiometric Survey at the Aurora Uranium Project, Athabasca Basin, Saskatchewan

Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to report results of a property-wide airborne radiometric survey at the Aurora project ("Aurora" or the "Project"). Aurora is located …

CAMP4 Therapeutics Closes Second Tranche of Private Placement, Raising $50.1 Million to Advance CMP-002 Development

CAMP4 Therapeutics announced the closing of a second tranche of its private placement, raising approximately $50.1 million. These funds will primarily be used to advance CMP-002, its lead investigational therapy for SYNGAP1-related disorder, into a Phase 1/2 clinical trial, and to support its early-stage …

CAMP4 Therapeutics (Nasdaq: CAMP) raises $50.1M in second private placement closing

CAMP4 Therapeutics has completed the second closing of its $100 million private placement, raising approximately $50.1 million in gross proceeds. The company issued common stock and pre-funded warrants to institutional and accredited investors, as well as to certain directors and employees. The funds will …